UnknownPhase 4NCT00196768

Treatment Protocol for Relapsed Acute Promyelocytic Leukemia (APL) With Arsenic

Studying Acute promyelocytic leukemia

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
German AML Cooperative Group
Principal Investigator
Eva Lengfelder, MD, PhD
German AMLCG
Intervention
Arsenic trioxide(drug)
Enrollment
30 enrolled
Eligibility
18 years · All sexes
Timeline
2005 – 2010

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00196768 on ClinicalTrials.gov

Other trials for Acute promyelocytic leukemia

Additional recruiting or active studies for the same condition.

See all trials for Acute promyelocytic leukemia →

← Back to all trials